The company has significantly improved its financial stability by reducing total debt from $614.1M in 2023Q4 to $190.6M as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Total Current Assets | 722.3M | 680.07M | 815.49M | 927.57M | 881.81M | 780.7M | 829.41M | 483.24M | 397.13M | 367.12M | 315.41M | 264.13M | 283.38M | 233.78M | 180.88M | 279.39M | 268.49M | 251.22M | 225.29M | 252.18M | 129.85M | 85.59M | 77.77M | 63.54M | 48.45M | 59.96M | 36.15M |
| Cash & Short-Term Investments | 239.22M | 196.52M | 381.68M | 467.97M | 341.85M | 359.72M | 496.17M | 136.98M | 67.19M | 32.42M | 54.49M | 82.22M | 125.89M | 104.53M | 62.31M | 199.87M | 183.71M | 169.23M | 120.44M | 169.81M | 60.86M | 29.54M | 30.6M | 33.52M | 21.48M | 23.84M | 11.97M |
| Cash Only | 239.22M | 196.52M | 369.2M | 467.97M | 330.36M | 349.05M | 485.93M | 127.21M | 67.19M | 32.42M | 54.49M | 82.22M | 125.89M | 104.53M | 62.31M | 191.76M | 175.63M | 169.23M | 120.44M | 169.81M | 60.86M | 29.54M | 19.48M | 24.5M | 21.4M | 16.91M | 9.68M |
| Short-Term Investments | 0 | 0 | 12.47M | 0 | 11.49M | 10.66M | 10.25M | 9.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.11M | 8.07M | 0 | 0 | 0 | 0 | 0 | 11.12M | 9.03M | 85K | 6.93M | 2.29M |
| Accounts Receivable | 249.8M | 216.86M | 256.4M | 263.89M | 299.47M | 240.89M | 190.12M | 218.36M | 196.24M | 198.81M | 150.3M | 107.96M | 82.76M | 58.6M | 55.12M | 36.9M | 42.73M | 45.88M | 57.98M | 37.52M | 36.05M | 29.46M | 24.84M | 17.27M | 12.34M | 18.17M | 11.04M |
| Days Sales Outstanding | 70.39 | 66.8 | 84.14 | 83.97 | 84.34 | 77.67 | 77.78 | 88.85 | 90.98 | 101.33 | 79.21 | 81.32 | 68.52 | 56.2 | 64.06 | 54.86 | 70.13 | 78.46 | 84.02 | 64.27 | 85.05 | 88.48 | 73.17 | 61.71 | 51.38 | 76.3 | 59.8 |
| Inventory | 99.2M | 100.91M | 88.66M | 110.1M | 147.55M | 119.92M | 96.3M | 108.01M | 100.87M | 96.14M | 69.3M | 46.59M | 31.55M | 31.46M | 26.9M | 18.11M | 9.79M | 9.58M | 12.96M | 13.73M | 15.72M | 13.76M | 14.59M | 8.78M | 12.74M | 12.7M | 10.41M |
| Days Inventory Outstanding | 54.49 | 54.05 | 50.47 | 62.09 | 76.18 | 75.81 | 73.39 | 85.68 | 88.72 | 89.04 | 66.77 | 71.87 | 55.63 | 64.8 | 68.44 | 60.22 | 34.18 | 32.31 | 38.38 | 50.24 | 82.95 | 92.16 | 102.36 | 75.5 | 127.7 | 141.49 | 143.02 |
| Other Current Assets | 134.08M | 132.08M | 61.48M | 51.36M | 64.17M | 31.01M | 20.7M | 1.06M | 12.14M | 4.5M | 12.67M | 7.77M | 19.66M | 20.31M | 21.03M | 16.46M | 16.44M | 16.35M | 24.3M | 21.64M | 9.18M | 10.29M | 0 | 2.74M | 0 | 0 | 0 |
| Total Non-Current Assets | 1.28B | 1.29B | 1.31B | 1.3B | 1.33B | 1.36B | 995.09M | 757.57M | 684.11M | 613.18M | 619.7M | 314.62M | 276.83M | 258.72M | 262.85M | 82.57M | 74.81M | 70.12M | 83.8M | 76.24M | 24.78M | 14.84M | 21.73M | 20.93M | 17.1M | 12.15M | 7.76M |
| Property, Plant & Equipment | 144.45M | 144.48M | 138.3M | 133.59M | 132.01M | 119.69M | 114.19M | 110.38M | 51.5M | 42.59M | 42.01M | 32.31M | 36.18M | 35.25M | 34.26M | 17.31M | 14.35M | 13.21M | 16.18M | 10.18M | 5.23M | 4.73M | 5.66M | 4.83M | 5.03M | 5.38M | 4.91M |
| Fixed Asset Turnover | 8.42x | 8.20x | 8.04x | 8.59x | 9.82x | 9.46x | 7.81x | 8.13x | 15.29x | 16.81x | 16.49x | 15.00x | 12.19x | 10.80x | 9.17x | 14.19x | 15.50x | 16.16x | 15.57x | 20.92x | 29.60x | 25.71x | 21.90x | 21.13x | 17.45x | 16.14x | 13.71x |
| Goodwill | 737.29M | 737.95M | 734.73M | 735.81M | 734.27M | 738.9M | 499.31M | 336.54M | 335.89M | 337.75M | 327.72M | 147.91M | 122.72M | 111.34M | 113.4M | 28.54M | 28.54M | 24.98M | 24.98M | 23.08M | 4.92M | 3.13M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 165.43M | 170.1M | 246.7M | 277.83M | 323.67M | 374.61M | 262.24M | 209.94M | 143.69M | 168.11M | 190.28M | 89.67M | 82.67M | 81.6M | 85.16M | 4.23M | 4.67M | 4.23M | 6.71M | 9.47M | 1.07M | 4.18M | 5.81M | 6.32M | 0 | 0 | 0 |
| Long-Term Investments | 227.22M | 60.74M | 52.74M | 54.8M | 32.92M | 18.39M | 22.16M | 19.75M | 17.08M | 15.44M | 20.59M | 14.48M | 10.85M | 11.48M | 13.23M | 8.79M | 9.22M | 8.71M | 10.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 122.36M | 123.04M | 75.53M | 64.37M | 83.74M | 94.32M | 82.18M | 66.83M | 120.76M | 39.84M | 35.05M | 27.89M | 23.27M | 17.94M | 15.78M | 9.72M | 8.37M | 9.32M | 8.9M | 20.63M | 13.56M | 4.48M | 10.26M | 9.77M | 12.07M | 6.77M | 2.85M |
| Total Assets | 2B | 1.97B | 2.12B | 2.23B | 2.21B | 2.14B | 1.82B | 1.24B | 1.08B | 980.3M | 935.1M | 578.75M | 560.21M | 492.5M | 443.73M | 361.97M | 343.3M | 321.34M | 309.09M | 328.42M | 154.63M | 100.43M | 99.49M | 84.47M | 65.54M | 72.11M | 43.91M |
| Asset Turnover | 0.61x | 0.60x | 0.52x | 0.52x | 0.59x | 0.53x | 0.49x | 0.72x | 0.73x | 0.73x | 0.74x | 0.84x | 0.79x | 0.77x | 0.71x | 0.68x | 0.65x | 0.66x | 0.81x | 0.65x | 1.00x | 1.21x | 1.25x | 1.21x | 1.34x | 1.21x | 1.53x |
| Asset Growth % | -35.53% | -6.89% | -4.76% | 0.73% | 3.19% | 17.43% | 47.04% | 14.76% | 10.3% | 4.83% | 61.57% | 3.31% | 13.75% | 10.99% | 22.59% | 5.44% | 6.84% | 3.96% | -5.89% | 112.39% | 53.97% | 0.94% | 17.79% | 28.87% | -9.11% | 64.25% | - |
| Total Current Liabilities | 483.05M | 476.61M | 595.68M | 367.79M | 428.45M | 876.16M | 276.42M | 237M | 204.58M | 212.54M | 180.91M | 124.63M | 112.33M | 93.07M | 84.98M | 58.75M | 57.96M | 57.63M | 57.6M | 57.82M | 53.56M | 33.78M | 42.05M | 44.14M | 48.47M | 52.15M | 49.6M |
| Accounts Payable | 58.34M | 43.99M | 51.78M | 45.03M | 63.39M | 71.51M | 40.31M | 46.38M | 38.04M | 48.29M | 27.07M | 22.65M | 19.43M | 16.47M | 18.25M | 11M | 13.24M | 10.31M | 9.38M | 10.12M | 8.79M | 4.06M | 4.49M | 2.92M | 5.97M | 4.84M | 4.42M |
| Days Payables Outstanding | 29.96 | 23.56 | 29.48 | 25.39 | 32.73 | 45.21 | 30.72 | 36.79 | 33.46 | 44.73 | 26.08 | 34.93 | 34.26 | 33.93 | 46.44 | 36.58 | 46.26 | 34.78 | 27.77 | 37.01 | 46.38 | 27.18 | 31.49 | 25.11 | 59.88 | 53.88 | 60.65 |
| Short-Term Debt | 0 | 11.96M | 174.32M | 0 | 0 | 488.15M | 0 | 0 | 0 | 15.21M | 8.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 305K | 1.2M | 0 | 37K |
| Deferred Revenue (Current) | 784.44M | 171.86M | 201.98M | 132.28M | 187.21M | 152.11M | 125.2M | 94.9M | 81.83M | 86.1M | 87.52M | 53.66M | 53.73M | 42.58M | 41.22M | 33.4M | 28.51M | 14.46M | 12.08M | 11.26M | 7.71M | 14.51M | 13.92M | 12.65M | 11.6M | 32.8M | 3.23M |
| Other Current Liabilities | 212.82M | 191.63M | 0 | 126.02M | 73.45M | 71.13M | 55.75M | 44.16M | 124.88M | 114.47M | 118.71M | 30.13M | 19.3M | 13.75M | 11.43M | 5.45M | 7.73M | 0 | 16.01M | 15.26M | 10.22M | 2.55M | 10.72M | 12.86M | 18.01M | 24.79M | 25.85M |
| Current Ratio | 1.50x | 1.43x | 1.37x | 2.52x | 2.06x | 0.89x | 3.00x | 2.04x | 1.94x | 1.73x | 1.74x | 2.12x | 2.52x | 2.51x | 2.13x | 4.76x | 4.63x | 4.36x | 3.91x | 4.36x | 2.42x | 2.53x | 1.85x | 1.44x | 1.00x | 1.15x | 0.73x |
| Quick Ratio | 1.29x | 1.22x | 1.22x | 2.22x | 1.71x | 0.75x | 2.65x | 1.58x | 1.45x | 1.28x | 1.36x | 1.75x | 2.24x | 2.17x | 1.81x | 4.45x | 4.46x | 4.19x | 3.69x | 4.12x | 2.13x | 2.13x | 1.50x | 1.24x | 0.74x | 0.91x | 0.52x |
| Cash Conversion Cycle | 94.93 | 97.29 | 105.13 | 120.67 | 127.8 | 108.28 | 120.45 | 137.74 | 146.24 | 145.64 | 119.89 | 118.26 | 89.89 | 87.07 | 86.06 | 78.49 | 58.05 | 76 | 94.62 | 77.5 | 121.62 | 153.46 | 144.04 | 112.1 | 119.19 | 163.91 | 142.17 |
| Total Non-Current Liabilities | 264.43M | 266.3M | 281.97M | 670.13M | 652.17M | 119.65M | 580.58M | 158.56M | 197.04M | 250.57M | 322.58M | 51.73M | 57.79M | 51.1M | 51.16M | 20.3M | 19.85M | 21.41M | 17.94M | 15.96M | 11.08M | 11.41M | 3.74M | 5.57M | 763K | 363K | 19.33M |
| Long-Term Debt | 190.56M | 167.6M | 166.4M | 569.66M | 566.57M | 0 | 467.2M | 50M | 135.42M | 194.92M | 245.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.29M | 3.22M | 0 | 305K | 363K | 8.38M |
| Capital Lease Obligations | 105.81M | 24.79M | 31.12M | 33.91M | 39.41M | 39.91M | 48.9M | 50.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 3.9M | 683K | 1.11M | 1.62M | 2.1M | 51.7M | 39.63M | 39.09M | 41.48M | 28.58M | 51.59M | 21.82M | 30.45M | 28.16M | 26.4M | 11.68M | 9.57M | 9.67M | 15.89M | 12.88M | 0 | -9.87M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 10.16M | 9.97M | 7.22M | 6.32M | 6.72M | 7.84M | 19.17M | 11.72M | 9.56M | 9.83M | 8.21M | 11.93M | 7.02M | 5.17M | 30.31M | 1.34M | 675K | 595K | 1.15M | 237K | 995K | 250K | 517K | 5.57M | 458K | 0 | 10.96M |
| Total Liabilities | 747.48M | 742.91M | 877.65M | 1.04B | 1.08B | 995.81M | 857M | 395.56M | 401.63M | 463.11M | 503.5M | 176.36M | 170.12M | 144.17M | 136.15M | 79.05M | 77.81M | 79.03M | 75.53M | 73.78M | 64.63M | 45.19M | 45.79M | 49.71M | 49.24M | 52.51M | 68.93M |
| Total Debt | 190.56M | 204.34M | 382.55M | 614.09M | 616.74M | 541.01M | 528.29M | 110.73M | 135.42M | 210.13M | 254.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.16M | 3.22M | 305K | 1.5M | 363K | 8.41M |
| Net Debt | -48.66M | 7.83M | 13.35M | 146.12M | 286.38M | 191.96M | 42.37M | -16.48M | 68.22M | 177.7M | 199.65M | -82.22M | -125.89M | -104.53M | -62.31M | -191.76M | -175.63M | -169.23M | -120.44M | -169.81M | -60.86M | -18.38M | -16.26M | -24.19M | -19.9M | -16.55M | -1.27M |
| Debt / Equity | 0.15x | 0.17x | 0.31x | 0.52x | 0.55x | 0.47x | 0.55x | 0.13x | 0.20x | 0.41x | 0.59x | - | - | - | - | - | - | - | - | - | - | 0.20x | 0.06x | 0.01x | 0.09x | 0.02x | - |
| Debt / EBITDA | 1.72x | 2.43x | 4.25x | 8.06x | 6.37x | 3.10x | 4.93x | 0.78x | 1.41x | 3.67x | 3.92x | - | - | - | - | - | - | - | - | - | - | 7.47x | 0.22x | 0.03x | - | 0.11x | - |
| Net Debt / EBITDA | -0.44x | 0.09x | 0.15x | 1.92x | 2.96x | 1.10x | 0.40x | -0.12x | 0.71x | 3.10x | 3.08x | -1.11x | -1.80x | -1.95x | -1.54x | -7.92x | -9.68x | -16.76x | -4.58x | -7.44x | -4.69x | -12.30x | -1.11x | -2.31x | - | -5.03x | - |
| Interest Coverage | 18.41x | 2.84x | 0.07x | - | -17.87x | 4.00x | 16.94x | 13.50x | - | - | - | 18.92x | 45.95x | 289.34x | 935.38x | 260.50x | 2490.25x | 80.47x | 1382.47x | - | - | - | - | - | - | - | - |
| Total Equity | 1.26B | 1.23B | 1.24B | 1.19B | 1.13B | 1.15B | 967.5M | 845.25M | 679.62M | 517.2M | 431.61M | 402.39M | 390.1M | 348.33M | 307.58M | 282.91M | 265.49M | 242.3M | 233.56M | 254.64M | 90M | 55.24M | 53.7M | 34.76M | 16.31M | 19.6M | -25.02M |
| Equity Growth % | 3.25% | -0.92% | 4.57% | 5.2% | -1.44% | 18.52% | 14.46% | 24.37% | 31.4% | 19.83% | 7.26% | 3.15% | 11.99% | 13.25% | 8.72% | 6.56% | 9.57% | 3.75% | -8.28% | 182.94% | 62.92% | 2.87% | 54.49% | 113.16% | -16.81% | 178.33% | - |
| Book Value per Share | 27.35 | 26.57 | 26.88 | 26.30 | 24.63 | 23.92 | 22.12 | 19.68 | 16.76 | 13.36 | 11.71 | 10.96 | 10.65 | 9.74 | 8.99 | 8.30 | 7.92 | 7.56 | 7.05 | 7.53 | 3.11 | 2.13 | 1.94 | 1.37 | 0.75 | 1.90 | -14.69 |
| Total Shareholders' Equity | 1.26B | 1.23B | 1.24B | 1.19B | 1.13B | 1.15B | 967.5M | 845.25M | 679.62M | 517.2M | 431.61M | 402.39M | 390.1M | 348.33M | 307.58M | 282.91M | 265.49M | 242.3M | 233.56M | 254.64M | 90M | 55.24M | 53.7M | 34.76M | 16.31M | 19.6M | -25.02M |
| Common Stock | 0 | 58K | 57K | 56K | 55K | 54K | 53K | 51K | 50K | 48K | 46K | 45K | 43K | 41K | 39K | 38K | 37K | 36K | 35K | 35K | 28K | 26K | 26K | 24K | 22K | 22K | 11.73M |
| Retained Earnings | 0 | 384.94M | 382.89M | 370.36M | 390.73M | 368.57M | 290.72M | 258.79M | 197.45M | 122.58M | 100.4M | 99.79M | 69.03M | 38.52M | 14.54M | -1.64M | -12.03M | -16.92M | -17.37M | -30.09M | -72.8M | -83.17M | -81.09M | -91.69M | -99M | -93.96M | -92.8M |
| Treasury Stock | 0 | -368.31M | -290.32M | -290.32M | -290.32M | -238.11M | -238.11M | -185.07M | -185.07M | -185.07M | -185.07M | -185.07M | -135.05M | -110.96M | -90M | -77.64M | -65.06M | -65.06M | -65.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -8.85M | -17.2M | -13.43M | -17.09M | -8.41M | -5.52M | -9.45M | -10.85M | -6.11M | -9.52M | -2.73M | -1.36M | 171K | 131K | 1K | 0 | 0 | 0 | 0 | 0 | 12K | -33K | -19K | -4.67M | -5.22M | -6.35M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hospital CAPEX budget sensitivity
According to reported financial statements, Omnicell has successfully reduced its total debt from $614.1M in 2023Q4 to $190.6M by 2026Q1, signaling a deliberate effort to strengthen the balance sheet despite the ongoing transition toward a subscription-based revenue model that creates short-term top-line volatility.
The significant reduction in debt levels suggests management is prioritizing financial flexibility as the company navigates a challenging hospital capital expenditure environment. This deleveraging trend appears to be a strategic response to the high-interest-rate climate, which previously necessitated a more conservative approach to capital structure.
Based on the provided quarterly data, the company's debt-to-equity ratio has improved from 0.52 in 2024Q1 to 0.15 in 2026Q1, indicating that Omnicell has significantly lowered its financial leverage and reduced the interest burden on its constrained operating cash flows.
The rapid paydown of debt suggests that the company is attempting to insulate itself from the cyclicality of hospital spending by minimizing fixed financial obligations. Investors should monitor whether this lower leverage profile provides sufficient cushion if the transition to recurring revenue models continues to pressure near-term profitability.
As reported in recent filings, goodwill remains a substantial component of the asset base at $737.3M as of 2026Q1, representing a significant portion of the $2.0B total assets and highlighting potential impairment risks if the acquired pharmacy automation businesses fail to meet growth expectations.
The high concentration of intangible assets relative to tangible property, plant, and equipment suggests that the company's value is heavily tied to past acquisitions rather than physical infrastructure. This asset mix warrants further investigation into the long-term performance of the acquired units, as any shortfall could necessitate non-cash write-downs that would impact equity.
Based on the latest 2026Q1 figures, Omnicell maintains a current ratio of 1.50, which, while lower than the 2.52 peak observed in 2023Q4, suggests the company retains an adequate buffer to meet short-term obligations despite the ongoing volatility in its working capital and cash conversion cycles.
The current liquidity position appears stable, though the fluctuation in the current ratio over the last ten quarters reflects the lumpy nature of large-scale hardware installations and associated revenue recognition. The company's ability to manage its cash runway while simultaneously reducing debt indicates a disciplined approach to liquidity management in a period of business model transition.
Quick answers to the most common questions about buying OMCL stock.
As of 2025, Omnicell, Inc. (OMCL) had total assets of $1.97B including $680.1M in current assets.
Omnicell, Inc. (OMCL) carries total debt of $204.3M, offset by $196.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Omnicell, Inc. (OMCL) has total shareholders' equity (book value) of $1.23B ($26.57 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Omnicell, Inc. (OMCL) reported a current ratio of 1.43x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.